Diabetes Metab Syndr 19(2):103185 Cruz-Jentoft AJ, Bahat G, Bauer J, Boirie Y, Bruyere O, Cederholm T et al (2019) Sarcopenia: revised European consensus on definition and diagnosis
Glenwood, LLC, Englewood, NJ, USA) was approved as a treatment option for Peyronie's disease in 1959 by the United States Food and Drug Administration, and became commercially available in South Korea from 2011 [7]
Until recently, oral glutathione was thought to be ineffective at raising intracellular levels of glutathione, due to the molecules being lost during digestion
Regulatory bodies including the MHRA and European Medicines Agency (EMA) continue to monitor safety data, and current product information for GLP-1 agonists includes cholelithiasis and cholecystitis as recognised adverse reactions
Patients with a history of pancreatitis are cautioned against the use of semaglutide due to the increased risk of pancreatic cancer
Decaisnea insignis seed oil inhibits trimethylamine-N-oxide formation and remodels intestinal microbiota to alleviate liver dysfunction in l-carnitine feeding mice